Mountain Crest III (MCAE) Re-Strikes ETAO Deal
by Marlena Haddad on 2022-06-13 at 6:00pm

Mountain Crest III (NASDAQ:MCAE) announced this afternoon that it has amended its merger agreement in connection to its proposed business combination with healthcare group ETAO.

As part of the amended merger agreement, Mountain Crest III has reduced ETAO’s valuation from $2.5 billion to just $1 billion due to unfavorable market conditions, ETAO’s financial statements, and its failure to close a private placement of its securities in the amount of $51 million that was scheduled to close on or before February 15, 2022. MCAE also noted that the amendment was made due to the uncertainty of the $250 million commitment in a private investment in its securities that is scheduled to close simultaneously with the deal.

Mountain Crest III originally brought $54.1 million into the deal supplemented by a $250 million PIPE at $10 per share with commitments from the China SME Investment Group. At the time, ETAO expected to also take in a $51 million investment prior to the deal’s close.

MCAE will now issue 100k ordinary shares at $10 per share as agreed by the parties to the shareholders of ETAO in exchange for 100% of the issued and outstanding shares.

Additionally, the amendment allows for the Sponsor to determine whether its designee will be an independent or dependent director on the board. If the Sponsor’s designee is dependent, then ETAO and the designee will enter into an agreement establishing the responsibilities and the compensation for the director prior to the closing of the merger.

The parties also extended the outside date for the closing of the deal from May 31, 2022 to October 5, 2022.

The last modification the parties made to the merger agreement pertained to ETAO’s failure to provide its audited financial statements for the years ended December 31, 2021 and 2020 as well as its reviewed condensed and consolidated financial statements for the six month periods ended June 30, 2022 and 2021. If the company is unable to obtain approval or consent from any Governmental Authority, including the Cyberspace Administration of China or the China Securities Regulatory Commission, by the outside date then that will constitute as a material failure by ETAO and the Shareholders’ Representative to perform its obligation.

MCAE originally announced the $2.5 billion deal with ETAO on January 28, 2022. Beijing-based ETAO is a diversified digital healthcare group managing 12 hospitals, about 30 chain clinics and an insurance brokerage.

 

 

Recent Posts
by Nicholas Alan Clayton on 2024-07-19 at 12:46pm

Vine Hill Capital Investment Corp. (NASDAQ:ESPAU) has filed for a $200 million IPO, which marks underwriter Stifel Nicolaus’ return to the SPAC market after a hiatus of over two years. Stifel last served as a book-runner for a SPAC when filing for Kensington Capital IV in January 2022 and hasn’t acted as left-lead since Spree...

by Nicholas Alan Clayton on 2024-07-19 at 8:13am

At the SPAC of Dawn SPACs may be back on the upswing, but it seems increasingly unlikely they will return to the same stomping grounds as in 2020-2022. Teams took 14 Fintech firms public during those years, 17 more in broader Financial Services and five more in Crypto. But, those sectors may no longer hold...

by Nicholas Alan Clayton on 2024-07-18 at 1:18pm

Expectation Acquisition Corporation (NASDAQ:ESPAU) has filed to bring another Oppenheimer alum back to the market with a $60 million SPAC IPO. That officer is Expectation CFO Chi Zhuang, who started out as an equity research associate at the firm’s New York office in 2014. This overlapped with a period when Lewis Silberman, co-CEO of yesterday’s...

by Kristi Marvin on 2024-07-18 at 10:19am

In the past few months we’ve seen a number of SPACs IPO using what we like to call “anchor investors”, a term we use as a bit of shorthand.  What that means is, the bankers round out the IPO with qualified institutional buyers, sometimes called “non-managing sponsor investors”, that indicate for up to 9.9% of...

by Nicholas Alan Clayton on 2024-07-18 at 8:20am

At the SPAC of Dawn Stardust Power (NASDAQ:SDST) is the latest de-SPAC to rocket up this week after closing its combination with Global Partner II, but there could be more to its spike than simply the low float it currently represents. The parties got through their July 8 closing with just 134,550 public shares remaining...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved